Surge in VC funding, dealmaking will improve biotech drug pipeline

06/20/2014 | Genetic Engineering & Biotechnology News

The recent uptick in venture capital investments in the biotechnology sector and the increasing number of partnerships between large and smaller biotech firms should help drugmakers replenish their pipeline and come up with better products in the future. Data from a Moneytree report showed that the biotech industry secured more than $4 billion in venture capital investments last year, an 8% growth, making it the second-biggest investment sector for venture capitalists for the year.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY